Susan de Jong

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

Thomas W. Geisbert, Amy CH Lee, Marjorie Robbins et al. · The Lancet · 2010 · 456 citations · Full text

Vaccination, Vaccine Development, Virus Epidemiology +10

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN

Susan de Jong, Ghania Chikh, Laura Sekirov et al. · Cancer Immunology Immunotherapy · 2007 · 132 citations · Full text

Nanoparticles, Nanomedicine, Cpg Odn +11

The Immunostimulatory Activity of Unmethylated and Methylated CpG Oligodeoxynucleotide Is Dependent on Their Ability To Colocalize with TLR9 in Late Endosomes

Susan de Jong, Genc Basha, Kaley D. Wilson et al. · The Journal of Immunology · 2010 · 45 citations · Full text

Immunology, Molecular Biology, Their Ability +19

Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles

Ghania Chikh, Susan de Jong, Laura Sekirov et al. · International Immunology · 2009 · 23 citations

The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine

Kaley D. Wilson, Susan de Jong, Mikameh Kazem et al. · The Journal of Gene Medicine · 2008 · 20 citations · Full text

Nanotherapeutics, Engineering, Immunology +25